Health Care & Life Sciences » Biotechnology | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. | Ownership

Companies that own Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Invesco Hong Kong Ltd.
25,236,000
7.42%
4,522,000
0.23%
01/26/2018
The Vanguard Group, Inc.
5,760,000
1.69%
0
0%
07/31/2018
Dimensional Fund Advisors LP
3,702,000
1.09%
107,000
0%
04/30/2018
FIL Investment Management (Hong Kong) Ltd.
1,775,977
0.52%
729
0%
05/31/2018
SSgA Funds Management, Inc.
1,230,000
0.36%
0
0%
09/06/2018
BlackRock Advisors (UK) Ltd.
1,061,000
0.31%
0
0%
09/05/2018
Norges Bank Investment Management
964,992
0.28%
235
0%
12/31/2017
Tokio Marine Asset Management Co., Ltd.
663,268
0.2%
-748,732
0.01%
09/20/2016
PineBridge Investments Asia Ltd.
273,000
0.08%
0
0%
04/30/2018
Mirae Asset Global Investments Co., Ltd.
233,234
0.07%
233,234
0%
04/30/2018

About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.

View Profile
Address
Zhangjiang Hi-Tech Park
Shanghai Shanghai 201210
China
Employees -
Website http://www.fd-zj.com
Updated 07/08/2019
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. engages in medical development. The company's activities include research and development, as well as commercialization of innovative drugs. It engages in genetic technical platform, photodynamic platform, nano technical platform and diagnosis technology platform.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.